Immedica Pharma AB

Solnavägen 3H
113 63 Stockholm
Sweden

Contact WebSite

Article

Immedica to Acquire Biopharma Company Marinus
03.01.2025 • News

Immedica to Acquire Biopharma Company Marinus

Stockholm, Sweden-headquartered global rare disease company Immedica Pharma has agreed to acquire Marinus Pharmaceuticals, a US commercial-stage pharmaceutical company developing therapies for seizure disorders, for enterprise value of approximately $151 million.